arbekacin

Metabolite details

Identifier

MKKYBZZTJQGVCD-XTCKQBCOSA-N

InChI Key

MKKYBZZTJQGVCD-XTCKQBCOSA-N

IUPAC name

(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-α-D-glucopyranosyloxy)-4-(2,6-diamino-2,3,4,6-tetradeoxy-α-D-erythro-hexopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide

Preferred name

arbekacin

INN name

arbekacin

Synonym

ABK

ChEBI

CHEBI:37922

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
• Microbial Diversity and Non-volatile Metabolites Profile of Low-Temperature Sausage Stored at Room Temperature
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
• Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
• Control_vs_Day_12
• G1_PBS_vs_G2_DSS
• Normal_vs_Neural_Tube_Defect
• Male_19_days_vs_Male_1_day
• Control_0d_vs_Treatment_180d
• CIDP_patient_vs_healthy_control